Headquartered in Woonsocket, Rhode Island, CVS Health Corporation (CVS) is a healthcare platform that spans retail pharmacies ...
Zacks Investment Research on MSN
CVS Health Delivers MBR Improvement: Is More Progress in the Cards?
CVS Health’s CVS Health Care Benefits segment recorded a medical benefit ratio (MBR) of 92.8% in the third quarter of 2025 compared with 95.2% in the prior year. The metric shows the percentage of ...
Bowl of Quick Cook on MSN
CVS Health's Strategic Realignment: Hundreds of Store Closures Signal a Pivot in Retail Pharmacy for 2025 and Beyond
CVS Health is undertaking a significant strategic realignment of its retail footprint, with plans to close hundreds more ...
Shares of CVS Health Corporation (NYSE:CVS) are trading lower on Thursday. This move could break important support. A new downtrend may be about to form. Our team of expert traders and technical ...
CVS Health Corporation’s stock (NYSE:CVS) is trading lower Thursday amid news of a lawsuit filed by the U.S. Department of Justice against CVS Pharmacy Inc., a subsidiary of CVS Health. Here’s what ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
TipRanks on MSN
CVS Health Appoints J. David Joyner as Board Chair
CVS Health ( ($CVS) ) has shared an announcement. On November 20, 2025, CVS Health announced the appointment of J. David ...
CVS Health Corp (NYSE:CVS) shares are trading slightly lower by 0.4% to $51.91 during Thursday’s session. Shares of insurers and pharmacy benefit manager stocks are trading lower in possible reaction ...
Zacks Investment Research on MSN
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...
On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results